Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Aiko Hirano"'
Autor:
Aiko Hirano, Aki Sakashita, Wataru Fujii, Kevin Baßler, Taisuke Tsuji, Masatoshi Kadoya, Atsushi Omoto, Noriya Hiraoka, Tatsuya Imabayashi, Yoshiko Kaneko, Hideaki Sofue, Yosuke Maehara, Takahiro Seno, Makoto Wada, Masataka Kohno, Wataru Fukuda, Kei Yamada, Koichi Takayama, Yutaka Kawahito
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Interstitial lung disease (ILD) is a serious complication of connective tissue diseases (CTDs). The heterogeneity of ILDs reflects differences in pathogenesis among diseases. This study aimed to clarify the characteristics of CTD-ILDs via a detailed
Externí odkaz:
https://doaj.org/article/c74a80d806f54f038f14d6d7c774e2a5
Publikováno v:
RMD Open, Vol 8, Iss 2 (2022)
Externí odkaz:
https://doaj.org/article/4dbb41834e13494fb64efc4a2bb6ce4b
Autor:
Hideaki Sofue, Takashi Kida, Aiko Hirano, Satoshi Omura, Masatoshi Kadoya, Daiki Nakagomi, Yoshiyuki Abe, Naoho Takizawa, Atsushi Nomura, Yuji Kukida, Naoya Kondo, Yasuhiko Yamano, Takuya Yanagida, Koji Endo, Shintaro Hirata, Kiyoshi Matsui, Tohru Takeuchi, Kunihiro Ichinose, Masaru Kato, Ryo Yanai
Publikováno v:
Modern Rheumatology; Jul2024, Vol. 34 Issue 4, p767-774, 8p
Autor:
Aiko Hirano, Kazuki Fujioka, Takashi Kida, Satoshi Omura, Hideaki Sofue, Aki Sakashita, Tomoya Sagawa, Yu Isoda, Akiko Kasahara, Risa Sagawa, Wataru Fujii, Takahiro Seno, Makoto Wada, Masataka Kohno, Yutaka Kawahito
Publikováno v:
Lupus. 32:63-73
Belimumab is a therapeutic medication that inhibits the B-cell-activating factor (BAFF) used for systemic lupus erythematosus (SLE); however, the response sometimes varies among individuals, even when patients are stratified based on general clinical
Autor:
Fumihiro Ishikawa, Kiyofumi Ninomiya, Shinya Nakamura, Toshio Morikawa, Weijia Xie, Genzoh Tanabe, Yuuto Yoshimori, Aiko Hirano, Osamu Muraoka, Katsuki Takashima, Kana Nishida, Shinsuke Marumoto, Isao Nakanishi
Publikováno v:
RSC Advances. 11:3221-3225
We show that salacinol-type α-glucosidase inhibitors are ligand-compatible with the GH 31 family. Salacinol and its 3′-O-benzylated analogs inhibit human lysosomal α-glucosidase at submicromolar levels. Simple structure-activity relationship stud
Publikováno v:
Journal of Equine Science
The measurement of various body dimensions of horses plays a significant role in quality improvement, genetic breeding, health, and soundness. There has been significant advancement in the technology for acquiring stereoscopic images with a three-dim
Autor:
Akiko Kasahara, Takashi Kida, Aiko Hirano, Satoshi Omura, Hideaki Sofue, Aki Sakashita, Tomoya Sagawa, Mai Asano, Michiaki Fukui, Makoto Wada, Masataka Kohno, Yutaka Kawahito
Publikováno v:
Modern rheumatology. 32(5)
Objective To determine whether patients with polymyalgia rheumatica (PMR) are more susceptible to glucocorticoid-induced adrenal insufficiency, one of the barriers to glucocorticoid tapering strategies, compared to patients with rheumatoid arthritis
Autor:
Akiko Kasahara, Takashi Kida, Aiko Hirano, Satoshi Omura, Hideaki Sofue, Aki Sakashita, Tomoya Sagawa, Mai Asano, Michiaki Fukui, Makoto Wada, Masataka Kohno, Yutaka Kawahito
Publikováno v:
Modern Rheumatology; Sep2022, Vol. 32 Issue 5, p891-898, 8p
Autor:
Eishi Ashihara, Keisuke Nishioka, Takashi Kida, Aiko Hirano, Kazuki Fujioka, Tomoya Sagawa, Jeffrey Strovel, Aki Sakashita, Mithun Raje, Akiko Kasahara, Masataka Kohno, Takuya Inoue, Yutaka Kawahito, Hidetake Nagahara, Makoto Wada, Shunya Kaneshita, Makoto Yoshioka, Steven Fletcher
Publikováno v:
Pulmonary Pharmacology & Therapeutics. 70:102057
Pulmonary fibrosis is a progressive disease with poor prognosis and limited therapeutic options. In this study, we evaluated the potential therapeutic effects of CG223, a novel inhibitor of bromodomain and extra-terminal motif (BET) proteins, on pulm
Autor:
Yuji Tominaga, Kazue Moon, Miyako Kyogoku, Takeshi Hatachi, Yoshiyuki Shimizu, Kazuya Tachibana, Yu Inata, Aiko Hirano, Kanako Isaka, Muneyuki Takeuchi
Publikováno v:
Pediatric Critical Care Medicine
Objectives Healthcare-associated infections after pediatric cardiac surgery are significant causes of morbidity and mortality. We aimed to identify the risk factors for the occurrence of healthcare-associated infections after pediatric cardiac surger